Evidence map›Paper›PMID 31036072›Full record

ArticleStem cell research & therapy2019

Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation.

Kongtana Trakarnsanga, Daniel Ferguson, Deborah E Daniels, Rebecca E Griffiths, Marieangela C Wilson, Kathryn E Mordue, Abi Gartner, Tatyana N Andrienko, Annabel Calvert, Alison Condie and 5 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Blood Pharming of Red Cells.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  2. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Kongtana TrakarnsangaSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Daniel FergusonSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Deborah E DanielsSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Rebecca E GriffithsBristol Institute for Transfusion Sciences, National Health Service Blood and Transplant (NHSBT), Bristol, BS34 7QH, UK.
Marieangela C WilsonSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Kathryn E MordueSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Abi GartnerSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Tatyana N AndrienkoSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Annabel CalvertSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Alison CondieScottish National Blood Transfusion Service, Jack Copland Centre, Heriot Watt Research Park, Edinburgh, EH14 4AP, UK.
Angela McCahillScottish National Blood Transfusion Service, Jack Copland Centre, Heriot Watt Research Park, Edinburgh, EH14 4AP, UK.
Joanne C MountfordScottish National Blood Transfusion Service, Jack Copland Centre, Heriot Watt Research Park, Edinburgh, EH14 4AP, UK.
Ashley M ToyeSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
David J AnsteeBristol Institute for Transfusion Sciences, National Health Service Blood and Transplant (NHSBT), Bristol, BS34 7QH, UK.
Jan FrayneSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK. Jan.Frayne@Bristol.ac.uk.ORCID 0000-0002-1113-7761
University of Bristol · GBNational Health Service · GBScottish National Blood Transfusion Service · GBSiriraj Hospital · TH

Funding

Wellcome TrustWellcome Trust 087430/Z/08Wellcome Trust 102610
6 · The paper itself

Abstract

backgroundPluripotent stem cells are attractive progenitor cells for the generation of erythroid cells in vitro as have expansive proliferative potential. However, although embryonic (ESC) and induced pluripotent (iPSC) stem cells can be induced to undergo erythroid differentiation, the majority of cells fail to enucleate and the molecular basis of this defect is unknown. One protein that has been associated with the initial phase of erythroid cell enucleation is the intermediate filament vimentin, with loss of vimentin potentially required for the process to proceed.

methodsIn this study, we used our established erythroid culture system along with western blot, PCR and interegation of comparative proteomic data sets to analyse the temporal expression profile of vimentin in erythroid cells differentiated from adult peripheral blood stem cells, iPSC and ESC throughout erythropoiesis. Confocal microscopy was also used to examine the intracellular localisation of vimentin.

resultsWe show that expression of vimentin is turned off early during normal adult erythroid cell differentiation, with vimentin protein lost by the polychromatic erythroblast stage, just prior to enucleation. In contrast, in erythroid cells differentiated from iPSC and ESC, expression of vimentin persists, with high levels of both mRNA and protein even in orthochromatic erythroblasts. In the vimentin-positive iPSC orthochromatic erythroblasts, F-actin was localized around the cell periphery; however, in those rare cells captured undergoing enucleation, vimentin was absent and F-actin was re-localized to the enucleosome as found in normal adult orthrochromatic erythroblasts.

conclusionAs both embryonic and adult erythroid cells loose vimentin and enucleate, retention of vimentin by iPSC and ESC erythroid cells indicates an intrinsic defect. By analogy with avian erythrocytes which naturally retain vimentin and remain nucleated, retention in iPSC- and ESC-derived erythroid cells may impede enucleation. Our data also provide the first evidence that dysregulation of processes in these cells occurs from the early stages of differentiation, facilitating targeting of future studies.

Indexed as

Cell DifferentiationCells, CulturedErythroid CellsErythropoiesisHumansInduced Pluripotent Stem CellsProteomicsVimentinVimentin

Identifiers

PMID31036072
PMCPMC6489253
OpenAlexW2944114465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.